Literature DB >> 3041493

Musculoskeletal manifestations of systemic lupus erythematosus.

M E Cronin1.   

Abstract

The musculoskeletal system is involved in nearly all patients with SLE. Transient arthralgias or arthritis are common and, in some patients, there is a progression to rheumatoid-like nonerosive hand deformities (Jaccoud's syndrome). The major disabling type of joint disease in lupus is articular osteonecrosis, often induced by high-dose corticosteroids. Rare forms of musculoskeletal manifestations of lupus include spontaneous tendon rupture, crystalline arthropathies, subcutaneous calcifications, and inflammatory myopathy.

Entities:  

Mesh:

Year:  1988        PMID: 3041493

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  6 in total

1.  Toe walking as a presenting sign of systemic lupus erythematosus.

Authors:  M Basiaga; D Sherry
Journal:  Lupus       Date:  2015-05-13       Impact factor: 2.911

2.  Systemic lupus erythematosus in Saudi patients.

Authors:  S R Alballa
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

Review 3.  Rheumatic diseases presenting as sports-related injuries.

Authors:  Fabio Jennings; Elaine Lambert; Michael Fredericson
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

4.  Evaluation of Anti-Cyclic Citrullinated Peptide Autoantibodies and C-Reactive Protein in Common Autoimmune Skin Diseases with and without Arthritis.

Authors:  Bandana Kumari; Pawan Kumar; Radha Krishna Prasad Chaudhary
Journal:  J Clin Diagn Res       Date:  2017-07-01

5.  Outcomes of Systemic Lupus Erythematosus in Patients who Discontinue Hydroxychloroquine.

Authors:  Z Aouhab; H Hong; C Felicelli; S Tarplin; R A Ostrowski
Journal:  ACR Open Rheumatol       Date:  2019-10-18

Review 6.  Multiple avascular necrosis of bone and polyarticular septic arthritis in patients with systemic lupus erythematosus.

Authors:  María Galindo; Isabel Mateo; José L Pablos
Journal:  Rheumatol Int       Date:  2004-02-21       Impact factor: 3.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.